| Breakdown | Jan 2026 | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 582.70M | 542.50M | 510.90M | 463.40M | 364.40M |
| Gross Profit | 135.20M | 193.80M | 138.60M | 114.70M | 67.40M |
| EBITDA | 114.60M | 127.00M | 125.30M | 108.90M | 70.30M |
| Net Income | 31.20M | 47.80M | 49.50M | 44.20M | 8.10M |
Balance Sheet | |||||
| Total Assets | 660.90M | 615.60M | 552.10M | 537.20M | 536.00M |
| Cash, Cash Equivalents and Short-Term Investments | 18.80M | 16.50M | 11.30M | 11.70M | 38.30M |
| Total Debt | 208.50M | 184.40M | 145.80M | 172.70M | 230.30M |
| Total Liabilities | 306.40M | 268.70M | 236.30M | 269.00M | 316.40M |
| Stockholders Equity | 354.50M | 346.90M | 315.80M | 268.20M | 219.60M |
Cash Flow | |||||
| Free Cash Flow | 92.20M | 70.50M | 77.40M | 73.70M | 91.60M |
| Operating Cash Flow | 103.90M | 88.90M | 105.20M | 91.90M | 98.50M |
| Investing Cash Flow | -45.10M | -40.50M | -30.00M | -18.20M | -6.90M |
| Financing Cash Flow | -57.50M | -42.90M | -73.20M | -102.10M | -65.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £220.29M | 7.15 | 9.00% | 7.08% | 7.41% | -34.98% | |
65 Neutral | £1.63B | 10.92 | 105.88% | 3.99% | 4.39% | -1.37% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | £661.16M | 15.12 | -113.93% | 1.40% | 3.94% | ― | |
53 Neutral | £44.37M | 4.70 | 63.25% | ― | -2.65% | -18.90% | |
47 Neutral | £72.89M | -0.86 | -56.70% | ― | -38.65% | -792.57% | |
44 Neutral | £631.84M | -4.10 | -90.46% | 4.48% | -30.52% | -2064.92% |